Mariner, LLC Dexcom Inc Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Mariner, LLC holds 29,287 shares of DXCM stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,287

Previous 90,783 67.74%

Holding current value

$2.24 Million

Previous $10.3 Million 80.94%

% of portfolio

0.0%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $3.94 Million - $7.14 Million	-61,496 Reduced 67.74%	29,287 $1.96 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $720,434 - $917,278	6,531 Added 7.75%	90,783 $10.3 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $5.19 Million - $6.37 Million	45,439 Added 117.07%	84,252 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $324,229 - $533,267	4,295 Added 12.44%	38,813 $4.82 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $188,127 - $301,514	2,186 Added 6.76%	34,518 $3.22 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $108,646 - $126,526	966 Added 3.08%	32,332 $4.15 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $146,224 - $172,825	1,406 Added 4.69%	31,366 $3.64 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $207,436 - $299,437	2,441 Added 8.87%	29,960 $3.39 Million
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $567,433 - $699,945	7,432 Added 37.0%	27,519 $2.22 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.37 Million - $2.67 Million	20,087 New	20,087 $1.5 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $186,887 - $230,387	-5,260 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $146,438 - $204,719	5,260 New	5,260 $788,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account